doc. MUDr. Alexandr Poprach, Ph.D.

2017

• MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX

  KISS Igor MLČOCHOVÁ Jitka SOUČKOVÁ Kamila FABIAN Pavel POPRACH Alexandr HALÁMKOVÁ Jana SVOBODA Marek VYZULA Rostislav SLABÝ Ondřej

  Article in Periodical

  Oncology letters, year: 2017, volume: 14, edition: 1, DOI

• Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer

  BUCHLER T. POPRACH Alexandr BORTLÍČEK Zbyněk LAKOMÝ Radek CHLOUPKOVÁ Renata VYZULA Rostislav ZEMANOVA M. KOPECKOVA K. SVOBODA Marek SLABÝ Ondřej KISS Igor STUDENTOVA H. HORNOVA J. FIALA O. KOPECKY J. FINEK J. DUŠEK Ladislav MELICHAR B.

  Article in Periodical

  CLINICAL GENITOURINARY CANCER, year: 2017, volume: 15, edition: 6, DOI

• Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed

  FIALA O. HOSEK P. PESEK M. FINEK J. RACEK J. BUCHLER T. POPRACH Alexandr HEJDUK Karel CHLOUPKOVÁ Renata SOREJS O. ECKSTEINOVA M. VITOVEC M. CIZKOVA K. KUCERA R. TOPOLCAN O.

  Article in Periodical

  Neoplasma, year: 2017, volume: 64, edition: 4, DOI

• The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab

  FIALA O. PITULE P. HOSEK P. LISKA V. SOREJS O. BRUHA J. VYCITAL O. BUCHLER T. POPRACH Alexandr TOPOLCAN O. FINEK J.

  Article in Periodical

  Tumor Biology, year: 2017, volume: 39, edition: 7, DOI

• Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry

  LAKOMÝ Radek POPRACH Alexandr BORTLÍČEK Zbyněk MELICHAR B. CHLOUPKOVÁ Renata VYZULA Rostislav ZEMANOVA M. KOPECKOVA K. SVOBODA Marek SLABÝ Ondřej KISS Igor STUDENTOVA H. JURÁČEK Jaroslav FIALA O. KOPECKY J. FINEK J. DUŠEK Ladislav HEJDUK Karel BUCHLER T.

  Article in Periodical

  BMC Cancer, year: 2017, volume: 17, edition: 880, DOI

• Zvládání nežádoucích účinků imunoterapie u pacientů s metastatickým renálním karcinomem

  POPRACH Alexandr LAKOMÝ Radek

  Chapter of a book

  Karcinom ledviny, edition: Vyd. První, year: 2017, number of pages: 6 s.

2016

• Baseline peripheral blood biomarkers predict clinical outcome ofadvanced melanoma patients treated with ipilimumab: singleinstitution real-life data experience

  FĚDOROVÁ Lenka POPRACH Alexandr LAKOMÝ Radek SELINGEROVÁ Iveta PILATOVA K VALIK D PETRÁKOVÁ Katarína VYZULA Rostislav ZDRAZILOVA-DUBSKA L KOZAKOVA S DEMLOVA R

  Article in Periodical

  Journal for ImmunoTherapy of Cancer, year: 2016, edition: 5(Suppl 1):A34

• Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients

  ILIEV Robert STANÍK Michal FEDORKO Michal POPRACH Alexandr VYCHYTILOVÁ Petra SLABÁ Kateřina SVOBODA Marek FABIAN Pavel PACÍK Dalibor DOLEŽEL Jan SLABÝ Ondřej

  Article in Periodical

  ONCOTARGETS AND THERAPY, year: 2016, volume: 9, edition: January, DOI

• Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients

  KISS Igor MLČOCHOVÁ Jitka BORTLÍČEK Zbyněk POPRACH Alexandr DRÁBEK Jiří VYCHYTILOVÁ Petra SVOBODA Marek BÜCHLER Tomáš BATKO Stanislav RYŠKA Aleš HAJDÚCH Marian SLABÝ Ondřej

  Article in Periodical

  Anticancer Research, year: 2016, volume: 36, edition: 9, DOI

• Efficacy of Sunitinib in Elderly Patients with Metastatic Renal Cell Carcinoma: Data from Real-World Clinical Practice

  POPRACH Alexandr LAKOMÝ Radek BORTLÍČEK Zbyněk MELICHAR Bohuslav PAVLÍK Tomáš SLABÝ Ondřej VYZULA Rostislav SVOBODA Marek KISS Igor STUDENTOVA Hana ZEMANOVA Milada FIALA Ondrej KUBACKOVA Katerina DUŠEK Ladislav HORNOVA Jana BUCHLER Tomas

  Article in Periodical

  Drugs & Aging, year: 2016, volume: 33, edition: 9, DOI